ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Hand Transplantation in Its Thirteenth Year: The Innsbruck Clinic Experience

    A. Weissenbacher, G. Pierer, M. Gabl, M. Ninkovic, T. Hautz, B. Zelger, W. Löscher, M. Kumnig, M. Rieger, R. Margreiter, J. Pratschke, G. Brandacher, S. Schneeberger

  • Hanging Donors: Are We Still Skeptical about Those Lungs?

    P. Mohite, D. Saez, A. Sabashnikov, B. Zych, N. Patil, A. Moza, F. DeRobertis, T. Bahrami, M. Amrani, A. Reed, M. Carby, A. Simon

  • Harmonization of an LC-MS/MS Assay for Therapeutic Drug Monitoring of Tacrolimus

    C. Joynes, D. Mason, T. Annesley, E. Champarnaud, C. Mussell, L. Calton, L. Harter, D. McKeown

  • Has Displaying KDPI in DonorNet® Led to a Spike in Discard Rates for Lower Quality Kidneys?

    D. Stewart, C. Samana, W. Cherikh, R. Formica, J. Friedewald

  • Has the VA Found a Way To Reduce Racial Disparities in Kidney Transplant Evaluation? Preliminary Results from the National VA Kidney Transplant Study

    L. Myaskovsky, J. Pleis, M. Ramkumar, A. Mittalhenkle, A. Langone, C. Thomas

  • Have Livers? Will Travel! Multiple Listings To Expedite Liver Transplantation

    P. Vagefi, J. Dodge, S. Feng, J. Roberts

  • Health-Related Quality of Life (HRQOL) of Recipients after Living-Donor Liver Transplantation (LDLT)

    J. Togashi, Y. Sugawara, N. Akamatsu, S. Tamura, J. Kaneko, T. Aoki, Y. Sakamoto, K. Hasegawa, N. Kokudo

  • Health-Related Quality of Life and Adherence to Medication in Kidney Transplantation: A Longitudinal Analysis

    F. Ortiz, R. Roine, R. Malmström, P. Koskinen

  • Health-Related Quality of Life in the Pre-Transplant Candidate Low MELD for End-Stage Liver Disease (MELD) Score: A Pilot Study

    R. Duke

  • Heat Shock Protein 90 Is Involved in Antibody-Mediated Rejection and Is a Potential Target of Anti-Rejection Therapy in Kidney Transplantation

    T. Tanaka, H. Ishida, M. Furusawa, Y. Tamura, H. Kitamura, S. Takahashi, N. Masumori, K. Tanabe, N. Sato, T. Tsukamoto

  • Heavy Water and Hydrogen Gas Confer Protection Against Hepatic Cold Ischemia and Reperfusion Injury in Isolated Perfused Rat Liver

    S. Shimada, M. Fukai, K. Wakayama, K. Yamashita, M. Taniguchi, T. Suzuki, T. Shimamura, T. Kamiyama, H. Furukawa, S. Todo, A. Taketomi

  • Heparin Induced Thrombocytopenia in Cardiac Transplant Recipients: Incidence and Complications

    Y. Alkhatib, S. Hassan, M. Qayum, U. Qayum, S. Amer, C. Mittal, P. Kuriakose

  • Hepatitis C Recurrence (HCVR) in Liver Transplant Recipients (OLT): Significant Reduction in Tacrolimus (FK) Dosage Can Be Safely Achieved in Patients Rendered Aviremic after Response-Guided Therapy (RGRx) Using Telaprevir (TVR)

    P. Mantry, C. Fasola, C. Wu, J. Weinstein, A. Mubarak, H. Nazario, A. Mejia, R. Dickerman, S. Cheng

  • Hepatitis C Virus Induced Changes in miRNA-449a Modulates the Expression of the Inflammatory Biomarker CCL2 through IL6 Receptor

    N. Sarma, V. Tiriveedhi, J. Crippin, W. Chapman, T. Mohanakumar

  • Hepatitis C Virus Infection Promotes Development of Fibrosis through Modulation of miR200c Regulates Growth Factor Signaling through FAP-1

    S. Ramachandran, H. Basha, J. Crippin, W. Chapman, T. Mohanakumar

  • Heterogeneity in Transcripts Induced in Implantation Biopsies: Distinguishing Preexisting Injury from Acute Phase Response

    K. Famulski, D. de Freitas, J. Reeve, P. Halloran

  • High BMI Is Not a Risk Factor for Mortality or Rejection Following Renal Transplantation

    N. Krishnan, R. Higgins, A. Short, D. Zehnder, D. Pitcher, A. Hudson, N. Raymond

  • High Cost of High MELD Waitlisted Patients, The

    D. Axelrod, N. Dzebisashvili, K. Lentine, J. Tuttle-Newhall, R. Freeman, M. Schnitzler

  • High Creatinine and Advanced Chronic Rejection (CR) Predicts Graft Loss in Non Adherent Kidney Transplant Recipients

    B. Bista, S. Jackson, N. Issa, A. Matas, A. Kukla

  • High DSA Is Associated with Steroid-Resistant Rejections in Liver Transplantation

    H. Kaneku, A. Zarrinpar, P. Terasaki, R. Busuttil

  • High Frequency of Valganciclovir Under- and Overdosing for CMV Prophylaxis after Renal Transplantation

    O. Rissling, M. Naik, S. Brakemeier, A. Hohberger, H. Neumayer, K. Budde

  • High Incidence of De Novo Post-Transplant Skin Cancer among Caucasian Recipients after Kidney Transplantation – An Analysis of OPTN/UNOS Data

    Y. Cho, I. Hutchinson, T. Shah

  • High Levels of Plasma IL-21 Together with EBV-Specific Cytotoxic T Cells (EBVTc) May Contribute Avoidance to Post-Transplant (Tx) Lymphoroliferative Disorder (PTLD) in Pediatric Kidney Tx Patients (pts) Who Had Persistent EBV Infection (PEBV)

    S. Ge, D. Puliyanda, W. Junji, A. Karasyov, E. Kamil, D. Lovato, R. Monette, S. Vikman, S. Jordan, M. Toyoda

  • High MFI Preformed Class II HLA Donor Specific Alloantibodies Increase the Risk of Early Rejection and Death after Liver-Transplantation

    J. O'Leary, H. Kaneku, L. Jennings, B. Susskind, P. Terasaki, G. Klintmalm

  • High Pre-Transplant Hepatitis B Virus (HBV) Level Predicts HBV Reactivation after Kidney Transplantation in HBV Infected Recipients

    J. Kim, S. Lee, H. Moon, J. Park, C. Kwon, S. Kim, J. Joh, S. Lee

  • High Rate of eRVR with Protease Inhibitor-Triple HCV Therapy in Liver Transplant Recipients: A Multicenter Study from CRUSH-C, A

    J. O'Leary, E. Verna, J. Burton, J. Lai, V. Saxena, J. Levitsky, J. Dodge, G. Everson, J. Trotter, R. Stravitz, R. Brown, N. Terrault

  • Higher IL10 Production by Transitional B Cells in Tolerant Kidney Transplant Recipients

    E. Nova Lamperti, P. Mobillo, Y. Kamra, G. Lord, R. Lechler, G. Lombardi, GAMBIT Consortium, M. Hernandez Fuentes

  • Higher KDPI Predicts Lower Renal Allograft Function and Higher Interstitial Fibrosis and Tubular Atrophy at 6 Months

    S. Chandran, Z. Laszik, R. Hirose, C. Freise, F. Vincenti

  • Histology One Year Post-Kidney Transplant Relates to Risk of Alloimmune-Mediated Graft Failure Long Term

    M. El Ters, L. Cornell, E. Rodrigo, M. Keddis, A. Muriithi, M. Stegall, F. Cosio

  • Histopathologic Predictors of Kidney Allograft Outcome in Patients with Transplant Glomerulopathy

    R. John, N. Mohamed, J. Kim

  • Histopathologic Scoring and Outcomes in Transplant Glomerulopathy (TG)

    R. Najjar, J. Kahwaji, D. Kancherla, A. Peng, R. Villicana, S. Jordan, A. Vo, M. Haas

  • History of Chronic Opioid Usage and Early Post Transplant Outcomes

    S. Kulshrestha, F. Barrantes, M. Kommareddi, M. Samaniego, F. Luan

  • HLA Antibody Increase Associated with Cardiac Surgery

    P. Warner, G. Aldea, M. Gallagher, K. Nelson

  • HLA Class I Antibody Augments FGF-23 Induced Transplant Vasculopathy and Chronic Antibody Mediated Rejection

    E. Tsai, Y. Jin, K. Wesseling-Perry, I. Salusky, R. Ettenger, E. Reed

  • HLA Class II Mismatch Is Associated with Higher Incidence of Antibody Mediated Rejection after Heart Transplantation

    A. Saidi, G. Snow, K. Brunisholz, E. Hammond, O. Wever-Pinzon, S. Drakos, C. Selzman, P. Revelo, R. Alharethi, D. Miller, J. Nativi-Nicolau, B. Reid, D. Budge, E. Gilbert, A. Kfoury, J. Stehlik

  • HLA Identical Renal Transplant Tolerance with Donor Hematopoietic Stem Cells Absent Chimerism: T and B Regulatory Cell and Genomic Analysis

    J. Leventhal, J. Mathew, D. Salomon, S. Kurian, M. Suthanthiran, A. Tambur, J. Friedewald, Y. Kanwar, M. Abecassis, J. Miller

  • HLA-Antigens as a Risk Factor in Polyomavirus BK Viremia

    P. Randhawa, T. Ninomiya, K. Masutani

  • HLA-DQ Mismatch Is an Independent Predictor of De Novo Donor-Specific HLA Antibodies after Liver Transplantation

    H. Kaneku, J. O'Leary, N. Bañuelos, L. Jennings, B. Susskind, G. Klintmalm, P. Terasaki

  • HLA-DR Mismatching Is Not Associated with Decreased Graft Survival in Highly Sensitized Kidney Recipients

    R. Ruhil, S. Talebagha, J. Beus, T. Pearson, H. Gebel, R. Bray, N. Turgeon

  • HLA-G Polymorphism, a Molecule Involved in Materno-Fetal Tolerance Is Associated with a Reduction of Acute Rejection and Improved Graft Survival in Renal Transplantation

    L. Quteineh, C. Verstuyft, B. Charpentier, L. Becquemont, A. Durrbach

  • How Do Anhepatic Patients Fair? A Single-Center Experience of Thirteen Patients Requiring Total Hepatectomy and Portocaval Shunting for Severe Hepatic Dysfunction

    K. Lau, A. Zarrinpar, V. Agopian, F. Kaldas, D. Farmer, R. Busuttil

  • How Should We Allocate Pediatric Deceased Donor Kidneys?

    W. Parker, C. Chesley, L. Ross, J. Thistlethwaite, Jr

  • How To Estimate Kidney Function in Kidney Transplant Recipients with Mild to Moderate Kidney Impairment. – Comparison of eGFR Values between Creatinine-Based GFR Equation and Cystatin C-Based Equation for Japanese

    M. Tsujita

  • How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients

    F. Saint-Marcoux, J. Woillard, J. Friedl, F. Bocquentin, M. Essig, P. Marquet

  • Human Adipose Tissue Derived Mesenchymal Stem Cells Aggravate Chronic Cyclosporin Nephrotoxicity by the Induction of Oxidative Stress

    B. Chung, S. Lim, K. Doh, S. Piao, S. Heo, C. Yang

  • Human Anti-Pig Xenogeneic T-Cell Response in the Absence of HD Antigen

    A. Shah, R. Sidner, L. Paris, J. Estrada, A. Tector

  • Human Insulinoma Expression of E2F Reveals a Role in Beta-Cell Proliferation and Quiescence

    B. Rady, Y. Chen, P. Vaca Sanchez, Q. Wang, Y. Wang, J. Oberholzer

  • Human Microbiota Characterization in the Course of Renal Transplantation

    J. Bromberg, W. Fricke

  • Human Regulatory B Cells (BRegs) Are Characterised by Both IL-10 and TNF-α Expression and Are Reduced in Numbers with Altered Function in Renal Transplant Recipients with Immunological Graft Injury

    A. Cherukuri, A. Salama, C. Carter, B. Clark, D. Rothstein, R. Baker

  • Human Thrombomodulin Regulates Complement Activation as Well as Coagulation in Xenoimmune Response

    H. Kim, J. Jeong, T. Koo, H. Jeon, H. Ro, M. Kim, J. Park, I. Yun, J. Yang, C. Ahn

  • Humoral Rejection of Human Kidney Grafts Associates with Polyreactive Antibodies That Bind Apoptotic Cells and Activate Complement

    F. Porcheray, J. Fraser, B. Gao, A. McColl, J. DeVito, I. Dargon, Y. Helou, W. Wong, T. Girouard, S. Saidman, R. Colvin, A. Palmisano, U. Maggiore, A. Vaglio, R. Smith, E. Zorn

  • Hybrid Procedure of Laparoscopic-Assisted Open Liver Resection in Living Donor Hepatectomy, A

    M. Takatsuki, A. Soyama, Y. Torashima, A. Kinoshita, T. Adachi, A. Kitasato, F. Fujita, K. Kanetaka, T. Kuroki, S. Eguchi

  • Hyperglycemia Augments Inflammatory Immune Responses in Liver Ischemia Reperfusion Injury (IRI) Via the RhoA/Akt Pathway

    S. Yue, J. Rao, J. Zhu, R. Bussutil, J. Kupiec-Weglinski, Y. Zhai

  • Hyperuricemia Is Associated with Both Histological Alteration in Implant Biopsy and Risk Factor of Donor’s Renal Function Decline after 1-Year in Living-Kidney Transplantation

    K. Tanaka, K. Sakai, T. Nemoto, Y. Ohashi, Y. Tanaka, M. Muramatsu, Y. Hyodo, T. Kawamura, S. Shishido, A. Aikawa

  • Hypogammaglobulinemia after Solid Organ Transplantation: Prevalence and Risk of Infections within the First Year

    D. Florescu, F. Qiu, U. Sandkovsky, A. Kalil

  • Hypothermic Machine Perfusion Improves Outcomes in DCD Kidneys

    L. Szabo, P. Laftsidis, A. Asderakis, E. Ablorsu

  • Hypothermic Machine Perfusion To Optimise the Timing of Renal Transplantation

    A. Guy, M. Field, H. Krishnan, N. Inston, A. Ready

  • Hypothermic Machine Perfusion with Ulinastatin in Pancreas Preservation Improved Islet Yield and Function in Islet Isolation

    X. Tian, Y. Li, X. Ding, X. Feng, H. Song, J. Hou, W. Xue, P. Tian, J. Zheng

  • Hypoxia Enhances Dendritic Cell Antigen Presentation through the Indirect Pathway

    S. Aiello, F. Rocchetta, N. Azzollini, P. Cassis, S. Solini, M. Mister, F. Casiraghi, G. Remuzzi, M. Noris

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences